×







We sell 100% Genuine & New Books only!

Tumors of the Brain and Spine 1st Editon 2007 Softbound at Meripustak

Tumors of the Brain and Spine 1st Editon 2007 Softbound by Franco DeMonte, Mark R. Gilbert, Anita Mahajan, Ian Earle McCutcheon, Springer

Books from same Author: Franco DeMonte, Mark R. Gilbert, Anita Mahajan, Ian Earle McCutcheon

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 8486.00/- [ 0.00% off ]

    Seller Price: ₹ 8486.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Franco DeMonte, Mark R. Gilbert, Anita Mahajan, Ian Earle McCutcheon
    PublisherSpringer
    Edition1st Edition
    ISBN9780387292014
    Pages364
    BindingSoftbound
    LanguageEnglish
    Publish YearJuly 2007

    Description

    Springer Tumors of the Brain and Spine 1st Editon 2007 Softbound by Franco DeMonte, Mark R. Gilbert, Anita Mahajan, Ian Earle McCutcheon

    It is frequently stated that progress in the management of tumors of the brain and spine has not occurred in the past 25 years. Such statements seriously underestimate and misrepresent progress in managing various central nervous system tumors, the tremendous technologic enhancements that have revolutionized the imaging of the tumors and the host organ, the multitude of surgical adjuncts such as computerized imaging guidance and functional mapping of the brain and its tracts that are routinely used in the modern neurosurgical operating room, and the highly conformal delivery of radiation to the tumor mass with remarkable sparing of the surrounding nervous tissue. Underlying these technologic improvements are the changes in philosophy that have resulted in a true multidisciplinary approach. Equally significant is the molecular revolution that is identifying key markers behind the genesis of brain tumors, their proliferation, and their resistance to therapy. These molecular discoveries have ushered in the era of molecular targeted therapy, as first demonstrated by the extraordinary success story in chronic myelogenous leukemia of imatinib (Gleevec). The rational combination of targeted agents will revolutionize the way che- therapy is given, either alone or in conjunction with radiotherapy. Lastly, focused attention to patients’ well-being has emphasized all measures of quality of life, has encouraged greater participation by patients and their caregivers in the decision-making process, and has encouraged the development of a variety of quality-of-life measurement tools to ensure that adverse effects of treatment are recognized and addressed. Epidemiology of Brain Tumors.- Neuropathology and Molecular Biology of Intracranial Tumors.- Radiology of Brain Tumors: Structure and Physiology.- Surgically Curable Brain Tumors of Adults.- Low-Grade Gliomas: Evidence-Based Treatment Options.- Surgical Strategies for High-Grade Gliomas.- Radiation Oncology for Tumors of the Central Nervous System: Improving the Therapeutic Index.- Cytotoxic Chemotherapy for Diffuse Gliomas.- Innovative Treatment Strategies for High-Grade Gliomas.- Pituitary Tumors in Oncology.- Management of Lung Cancer, Breast Cancer, and Melanoma Metastatic to the Brain.- Neoplastic Meningitis.- Lymphoma Affecting the Central Nervous System.- Tumors of the Extradural Spine.- Tumors of the Spinal Cord and Intradural Space.- Symptom Management for Patients with Brain Tumors: Improving Quality of Life.



    Book Successfully Added To Your Cart